FDA/Cryogen Labeling Dispute Attracts Congressional Interest

The House Commerce Committee has asked FDA Commissioner Jane Henney to review the agency's decision requiring Cryogen to submit a premarket approval application to expand the labeling of its First Option intrauterine cryosurgical probe to include specific references to endometrial ablation.

More from Archive

More from Medtech Insight